Iris International (IRIS) Inactive 10-Q2011 Q1 Quarterly report

Filed: 10 May 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: Accretion, accumulated, adequacy, adjusting, Amin, Analzyer, behalf, BioMicro, bought, brand, breast, broaden, build, building, built, CA, capacity, care, cell, Certification, characterization, Chatsworth, colorectal, compensatory, competitor, composed, contract, converted, Creditor, cytogenetic, default, delinquent, disposed, duly, entry, escrowed, Exhibit, external, family, feasibility, finite, FISH, flat, fluctutation, fluorescence, fluorescent, Fourth, Fujirebio, Garcia, Ginsburg, health, hybridization, identification, iii, impaired, impairment, infrastructure, John, joint, judgment, Khalifa, largest, leasehold, likelihood, lung, measure, measured, measuring, Mello, methodology, mild, milestone, nonpublic, obsolescence, open, passed, permanent, perod, Philip, Plant, point, policy, practice, predecessor, profile, program, promissory, promotional, proportionately, prototype, Randal, reduce, reduced, regional, Registrant, remanufactured, repetitive, resource, rest, restructuring, Robert, salability, seller, shown, significantly, size, slide, slightly, solid, sooner, standard, StatSpin, Step, Supplementary, taxable, technical, thereunto, ThermoBrite, Tom, trend, troubled, uncollectible, undersigned, undiscounted, Vance, version, veterinary, warrant, weak, white, workforce, worth, written, Yi

Removed: acid, Administration, ago, allocate, APR, AUTION, centrifuge, claim, classify, collected, condensed, consulting, cover, created, developing, device, digital, display, distribution, Drug, earlier, element, environment, evaluating, Exemption, experienced, expiration, Food, gland, GPO, iChem®VELOCITY, imaging, impacting, improvement, initiated, initiation, large, leased, manufacturing, marketable, MAX, men, monitor, morphology, neural, notification, nucleic, Particle, principle, prognostic, prostatectomy, PSA, radical, reached, recovery, recruiting, removal, repurchase, requesting, retained, retrospective, secondary, serially, study, submitted, subsidiary, supply, transition, undergone, undetectable

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IRIS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Quarterly Report of IRIS International, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2011 as filed with the Securities and Exchange Commission on the date thereof (the “Report”), I, César M. García, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 10, 2011	/s/ César M. García
	César M. García
	Chief Executive Officer

This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or the Exchange Act, or otherwise subject to the liability of Section 18 of the Exchange Act. Such certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.